Your browser doesn't support javascript.
loading
Selective inhibition of acylpeptide hydrolase in SAOS-2 osteosarcoma cells: is this enzyme a viable anticancer target?
Gogliettino, Marta; Cocca, Ennio; Sandomenico, Annamaria; Gratino, Lorena; Iaccarino, Emanuela; Calvanese, Luisa; Rossi, Mosè; Palmieri, Gianna.
Afiliación
  • Gogliettino M; Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), 80131, Napoli, Italy.
  • Cocca E; Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), 80131, Napoli, Italy.
  • Sandomenico A; Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), 80134, Napoli, Italy.
  • Gratino L; Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), 80131, Napoli, Italy.
  • Iaccarino E; Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), 80134, Napoli, Italy.
  • Calvanese L; Institute of Biostructure and Bioimaging, National Research Council (CNR-IBB), 80134, Napoli, Italy.
  • Rossi M; Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), 80131, Napoli, Italy.
  • Palmieri G; Institute of Biosciences and BioResources, National Research Council (CNR-IBBR), 80131, Napoli, Italy. gianna.palmieri@ibbr.cnr.it.
Mol Biol Rep ; 48(2): 1505-1519, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33471263

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Osteosarcoma / Inhibidores Enzimáticos / Terapia Molecular Dirigida Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Osteosarcoma / Inhibidores Enzimáticos / Terapia Molecular Dirigida Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2021 Tipo del documento: Article País de afiliación: Italia